Close

Synta's (SNTA) Ganetespib Could See Extra Exclusivity Following FDA Meeting - Roth

Go back to Synta's (SNTA) Ganetespib Could See Extra Exclusivity Following FDA Meeting - Roth
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) Delayed: 0.34 --0 (-0%)
Previous Close $0.34    52 Week High $2.23 
Open $4.10    52 Week Low $0.15 
Day High $0.34    P/E N/A 
Day Low $0.34    EPS $-1.25 
Volume 325,183